Search

Pristinamycin

NVS antibody

This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

Lactobacillus plantarum

*Lactobacillus plantarum* is a member of Lactobacillus, or lactic acid bacteria, that it is widely used in the food industry as a microbial starter and probiotic microorganism. … It is considered to be one of versatile species that carry out fermentative and metabolic processes, while exhibiting an antagonistic activity against pathogenic and spoilage microorganisms.

Gavestinel

Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo. … Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM).

Pipobroman

An antineoplastic agent that acts by alkylation.

Moexiprilat

The active metabolite of the prodrug Moexipril.

Cadralazine

Nizubaglustat

Nizubaglustat is under investigation in clinical trial NCT07054515 (A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type … C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis).

Trandolaprilat

The active metabolite of the prodrug Trandolapril.

Talampicillin